High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy

Iwona Homa-Mlak; Radosław Mlak; Anna Brzozowska; Marcin Mazurek; Tomasz Powrózek; Monika Prendecka-Wróbel; Aneta Szudy-Szczyrek; Piotr Dreher; Katarzyna Kamińska; Teresa Małecka-Massalska; Alicja Wójcik-Załuska

doi:10.12659/MSM.936857

01 September 2022 : Clinical Research

High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy

Iwona Homa-Mlak^1ACDEF*, Radosław Mlak^1ACDEF, Anna Brzozowska^2BDF, Marcin Mazurek^1CEF, Tomasz Powrózek^1CDE, Monika Prendecka-Wróbel^1CEF, Aneta Szudy-Szczyrek^2ADE, Piotr Dreher^3CEF, Katarzyna Kamińska^4F, Teresa Małecka-Massalska^1ACEF, Alicja Wójcik-Załuska^5CEG

DOI: 10.12659/MSM.936857

Med Sci Monit 2022; 28:e936857

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 ROC curve showing the diagnostic usefulness of irisin in detecting malnutrition (B or C according to the SGA scale).

Back to the Article

High Level of Irisin as a Marker of Malnutrition in Head and Neck Cancer Patients Subjected to Radiotherapy

Your Privacy